Moleculin Biotech, Inc.

Work to develop vaccines and treatments for COVID-19 is continuing around the world. Companies are joining forces to boost their efforts, and progress is being made on the research front. Meanwhile, t

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Hoth, Voltron Form JV To Dev

Ridgeback To Lead Development Of Emory University Viral Replication Inhibitor Privately held Ridgeback Biotherapeutics LP and Emory University y announced on 19 March they will work together to advan

Moderna Gets A $483m Assist From BARDA Moderna Inc. has received a major cash infusion from the US Biomedical Advanced Research and Development Authority (BARDA) to support its COVID-19 vaccine prog